Loading...
Request sample
Sign in to send a request. Suppliers are told your name, company, role and country.
- Scientific name
- -
- Active
- Palmitoylethanolamide (PEA)
- Assay
- min. 90 %
- Physical form
- Powder
- Dosage
- 350 mg
- MOQ · lead time
- 25 Kgs
About this ingredient
Levagen®+ by Saanroo is a cold-water dispersible palmitoylethanolamide (PEA) developed using patented LipiSperse® delivery technology. This innovation enhances bioavailability, stability, and functional versatility, allowing use in beverages, powders, capsules, and topicals. With a high active load (90%) and low excipients (10%), Levagen+® delivers consistent performance at lower dosages. Clinically studied across joint health, exercise recovery, cognitive support, sleep, immune health, and skin applications, Levagen+® provides formulators a multifunctional, GRAS, and cGMP-manufactured ingredient solution designed for diverse supplement and functional product development.
Categories
Cognitive healthJoint & bone healthMood & stressSleep
Technology
LipiSperse® Technology
Specification
6 parametersReproduced exactly as the manufacturer states them. A parameter the catalogue does not hold shows as a dash rather than a default.
Identity
| Parameter | Value |
|---|---|
| Active compound | Palmitoylethanolamide (PEA) |
| Technology | LipiSperse® Technology |
| Physical form | Powder |
Standardization
| Marker | Guaranteed level | Applies to | Test method |
|---|---|---|---|
| Standardization 1 | min. 90 % | - | - |
Use and handling
| Parameter | Value |
|---|---|
| Dosage studied | 350 mg |
| Minimum order quantity | 25 Kgs |
Applications
6 formatsFormats the supplier has run at commercial scale. No inclusion levels have been supplied for this listing yet.
BeveragesCapsulesFunctional BeveragesGummiesPowder BlendsTablets